Massive Bio

Private company

Our Artificial Intelligence (AI) based technology precisely identifies and matches patients clinical trials in community practices. Our proprietary technology is comprised of:

- Natural Language Processing for medical records, molecular diagnostics test results and clinical trial protocols; oncology proprietary ontology with 50, 000 elements specific to detailed oncology trial pre-screening

- Machine learning technology for scaled pre-screening; prescreening in the matter of seconds instead of hours

- Real world data platform that generates insights for drug discovery and development; thousands of full patient longitudinal journey for rapid insights

- AI powered patient identification technology; patients are found for pre-screening across the globe in the matter of seconds if they are in Massive Bio’s patient and provider network for trials


This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page